ID25978A - Antibodi anti-fas - Google Patents

Antibodi anti-fas

Info

Publication number
ID25978A
ID25978A IDP990903D ID990903D ID25978A ID 25978 A ID25978 A ID 25978A ID P990903 D IDP990903 D ID P990903D ID 990903 D ID990903 D ID 990903D ID 25978 A ID25978 A ID 25978A
Authority
ID
Indonesia
Prior art keywords
fas
fas antibody
abnormalities
mouse
reactive
Prior art date
Application number
IDP990903D
Other languages
English (en)
Indonesian (id)
Inventor
Nobufusa Serizawa
Hidiyukiharuyama
Kaori Nakahara
Ikuko Tamaki
Tohru Takashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID25978A publication Critical patent/ID25978A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP990903D 1998-09-30 1999-09-29 Antibodi anti-fas ID25978A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27688198 1998-09-30
JP27688298 1998-09-30

Publications (1)

Publication Number Publication Date
ID25978A true ID25978A (id) 2000-11-16

Family

ID=26552152

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990903D ID25978A (id) 1998-09-30 1999-09-29 Antibodi anti-fas

Country Status (14)

Country Link
EP (1) EP0990663A3 (de)
KR (1) KR20000023549A (de)
CN (1) CN1266714A (de)
AR (1) AR023333A1 (de)
AU (1) AU757961B2 (de)
BR (1) BR9904475A (de)
CA (1) CA2283540A1 (de)
HU (1) HUP9903299A3 (de)
ID (1) ID25978A (de)
IL (1) IL132139A0 (de)
NO (1) NO994750L (de)
NZ (1) NZ500019A (de)
PL (1) PL335752A1 (de)
RU (1) RU2223115C2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087993B1 (de) 1998-06-18 2008-04-02 Imed Ab Fas peptide und antikörper zur modulierung von apoptosis
JP4907843B2 (ja) 2002-03-25 2012-04-04 公益財団法人ひろしま産業振興機構 ヒト肝細胞増殖方法とヒト肝細胞の取得方法
AU2004319915B9 (en) * 2004-04-22 2011-12-22 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
WO2006004988A2 (en) * 2004-06-30 2006-01-12 Mayo Foundation For Medical Education And Research B7-dc binding antibody
CA2881717C (en) * 2006-06-06 2018-06-12 Cecilia Anna Wilhelmina Geuijen Human binding molecules having killing activity against staphylococci and uses thereof
EP2712930A3 (de) * 2006-12-06 2014-04-23 MedImmune, LLC Interferon-alpha-induzierte pharmakodynamische Marker
UA100255C2 (uk) * 2007-12-28 2012-12-10 Біоінвент Інтернешенл Аб Фармацевтична композиція
CA2742157A1 (en) * 2008-10-31 2010-05-06 Toray Industries, Inc. Immunoassay method for human cxcl1 protein
US8323652B2 (en) 2008-11-14 2012-12-04 Canadian Blood Services Antibodies against GPIbα
RU2519196C2 (ru) * 2011-07-01 2014-06-10 Олег Ильич Эпштейн Лекарственное средство для лечения патологического синдрома и способ лечения рассеянного склероза
TWI595007B (zh) 2012-09-10 2017-08-11 Neotope Biosciences Ltd 抗ｍｃａｍ抗體及相關使用方法
KR20160131082A (ko) * 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
JP2017514458A (ja) 2014-03-12 2017-06-08 プロセナ バイオサイエンシーズ リミテッド Ｌｇ４−５に対して特異的な抗−ラミニン４抗体
PT3116911T (pt) 2014-03-12 2019-09-04 Prothena Biosciences Ltd Anticorpos anti-mcam e métodos de utilização associados
MX2018004721A (es) * 2015-10-23 2018-07-06 Eureka Therapeutics Inc Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
CN111995681B (zh) * 2020-05-09 2022-03-08 华博生物医药技术（上海）有限公司 抗tigit的抗体、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123756A0 (en) * 1997-03-21 1998-10-30 Sankyo Co Humanized anti-human FAS antibody
IL123888A0 (en) * 1997-04-01 1998-10-30 Sankyo Co Anti-fas antibodies

Also Published As

Publication number Publication date
EP0990663A2 (de) 2000-04-05
HU9903299D0 (en) 1999-11-29
HUP9903299A3 (en) 2004-05-28
NZ500019A (en) 2001-06-29
NO994750D0 (no) 1999-09-29
AR023333A1 (es) 2002-09-04
PL335752A1 (en) 2000-04-10
BR9904475A (pt) 2000-12-12
AU5016199A (en) 2000-04-13
IL132139A0 (en) 2001-03-19
CN1266714A (zh) 2000-09-20
EP0990663A3 (de) 2002-04-17
KR20000023549A (ko) 2000-04-25
NO994750L (no) 2000-03-31
HUP9903299A2 (hu) 2000-11-28
AU757961B2 (en) 2003-03-13
CA2283540A1 (en) 2000-03-30
RU2223115C2 (ru) 2004-02-10

Similar Documents

Publication Publication Date Title
ID25978A (id) Antibodi anti-fas
FI901344A0 (fi) Monoklonala antikroppar reaktiva med tnf.
ATE437655T1 (de) Humanisierte anti-erbb2 antikörper und behandlung mit anti-erbb2 antikörper
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
ATE161582T1 (de) Monoklonale antikörper der maus
DE69129743D1 (de) Humanisierte chimäre anti-"icam-1" antikörper, herstellungsverfahren und verwendung
DE3854194D1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
NO20001104L (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende slike samt terapeutiske anvendelser derav
DE69126664D1 (de) Bestimmung von analyten in biologischen flüssigkeiten in gegenwart von störenden substanzen
FI961083L (fi) Rekombinentti-IL4-vasta-aineita, jotka ovat käyttökelpoisia IL-4-välitteisten häiriötilojen hoidossa
ID20117A (id) Antibodi anti-fas
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
ID20065A (id) Antibodi fas anti-manusia yang disesuaikan untuk manusia
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
DE69529744D1 (de) Monoklonale antikörper spezifisch gegen vaskuläres endothelzellartigen endoglyx-1, das antigen selbst und seine verwendungen
FR2773157B1 (fr) Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
ATE189897T1 (de) Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI971879L (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
TR199902410A2 (xx) Anti-Fas Antikorları
RU98104739A (ru) Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией
ATE106251T1 (de) Immunkomplexe.